GLP-1 agonists have already had an outsized influence on society, and with pill versions and more advanced formulations on the horizon, that looks set to continue
Več na: https://www.newscientist.com/article/mg26935761-800-2026-is-set-to-be-an-even-bigger-year-for-weight-loss-drugs/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home
nazaj